Metrics, dose, and dose concept: The need for a proper dose concept in the risk assessment of nanoparticles

International Journal of Environmental Research and Public Health

Volumn 11, Issue 4, 2014, Pages 4026-4048

  Simkó, Myrtill ^a,b   Nosske, Dietmar ^c   Kreyling, Wolfgang G ^d  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b AIT AUSTRIAN INSTITUTE OF TECHNOLOGY   (Austria)

^c BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Deposited nanoparticle dose; Dose rate; Effective dose; Equivalent dose; Nanoparticle surface area; Nanotoxicology; Radiation biology

Indexed keywords

METAL NANOPARTICLE; METAL OXIDE; NANOPARTICLE;

DISSOLUTION; PHYSICOCHEMICAL PROPERTY; RADIATION EXPOSURE; RISK ASSESSMENT; TOXICOLOGY;

ARTICLE; CANCER RISK; CARCINOGENICITY; CHEMICAL STRUCTURE; DISSOLUTION; DOSE CALCULATION; DOSIMETRY; ENERGY; IONIZING RADIATION; MATHEMATICAL MODEL; NANOTOXICOLOGY; PHYSICAL CHEMISTRY; RADIATION DOSE; RISK ASSESSMENT; SURFACE CHARGE; SURFACE PROPERTY; ZETA POTENTIAL;

DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; HUMANS; METAL NANOPARTICLES; MODELS, BIOLOGICAL; OXIDES; RADIATION DOSAGE; RADIATION, IONIZING; RISK ASSESSMENT;

EID: 84898870623     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110404026     Document Type: Article

References (41)

1. Hullmann, A. Who is winning the global nanorace? Nat. Nanotechnol. 2006, 1, 81-83.
2. Borm, P. J.; Robbins, D.; Haubold, S.; Kuhlbusch, T.; Fissan, H.; Donaldson, K.; Schins, R.; Stone, V.; Kreyling, W.; Lademann, J.; et al. The potential risks of nanomaterials: A review carried out for ecetoc. Part. Fibre Toxicol. 2006, 3, doi: 10. 1186/1743-8977-3-11.
3. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113, 823-839.
4. Balasubramanian, S. K.; Poh, K. W.; Ong, C. N.; Kreyling, W. G.; Ong, W. Y.; Yu, L. E. The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. Biomaterials 2013, 34, 5439-5452.
5. Bergin, I. L.; Witzmann, F. A. Nanoparticle toxicity by the gastrointestinal route: Evidence and knowledge gaps. Int. J. Biomed. Nanosci. Nanotechnol. 2013, 3, 163-210.
6. Benfenati, E.; Pardoe, S.; Martin, T.; Gonella Diaza, R.; Lombardo, A.; Manganaro, A.; Gissi, A. Using toxicological evidence from QSAR models in practice. Altex 2013, 30, 19-40.
7. Burello, E.; Worth, A. P. A rule for designing safer nanomaterials: Do not interfere with the cellular redox equilibrium. Nanotoxicology 2013, 2013, doi: 10. 3109/17435390. 2013. 828109.
8. Aranda, A.; Sequedo, L.; Tolosa, L.; Quintas, G.; Burello, E.; Castell, J. V.; Gombau, L. Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: A quantitative method for oxidative stress assessment of nanoparticle-treated cells. Toxicol. In Vitro 2013, 27, 954-963.
9. Burello, E.; Worth, A. P. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology 2011, 5, 228-235.
10. Burello, E.; Worth, A. Computational nanotoxicology: Predicting toxicity of nanoparticles. Nat. Nanotechnol. 2011, 6, 138-139.
11. Dusinska, M.; Dusinska, M.; Fjellsbo, L.; Magdolenova, Z.; Rinna, A.; Runden Pran, E.; Bartonova, A.; Heimstad, E.; Harju, M.; Tran, L.; et al. Testing strategies for the safety of nanoparticles used in medical applications. Nanomedicine (Lond.) 2009, 4, 605-607.
12. Burello, E.; Worth, A. P. Qsar modeling of nanomaterials. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2011, 3, 298-306.
13. Nel, A.; Xia, T.; Meng, H.; Wang, X.; Lin, S.; Ji, Z.; Zhang, H. Nanomaterial toxicity testing in the 21st century: Use of a predictive toxicological approach and high-throughput screening. Acc. Chem. Res. 2013, 46, 607-621.
14. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8, 543-557.
15. Puzyn, T.; Rasulev, B.; Gajewicz, A.; Hu, X.; Dasari, T. P.; Michalkova, A.; Hwang, H. M.; Toropov, A.; Leszczynska, D.; Leszczynski, J. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat. Nanotechnol. 2011, 6, 175-178.
16. Gajewicz, A.; Rasulev, B.; Dinadayalane, T. C.; Urbaszek, P.; Puzyn, T.; Leszczynska, D.; Leszczynski, J. Advancing risk assessment of engineered nanomaterials: Application of computational approaches. Adv. Drug Deliv. Rev. 2012, 64, 1663-1693.
17. Winkler, D. A.; Mombelli, E.; Pietroiusti, A.; Tran, L.; Worth, A.; Fadeel, B.; McCall, M. J. Applying quantitative structure-activity relationship approaches to nanotoxicology: Current status and future potential. Toxicology 2013, 313, 15-23.
18. Engineered Nanoparticles: Review of Health and Environmental Safety (ENRHES) Avaliable online: http://ihcp. jrc. ec. europa. eu/whats-new/enhres-final-report (accessed on 11 April 2014).
19. ENRHES. Engineered Nanoparticles: Review of Health and Environmental Safety (ENRHES); Final Report; January 2010. http://ihcp. jrc. ec. europa. eu/whats-new/enhres-final-report (down loaded 2010).
20. Castranova, V. Overview of current toxicological knowledge of engineered nanoparticles. J. Occup. Environ. Med. 2011, 53, S14-S17.
21. Borm, P. J.; Kelly, F.; Kunzli, N.; Schins, R. P.; Donaldson, K. Oxidant generation by particulate matter: From biologically effective dose to a promising, novel metric. Occup. Environ. Med. 2007, 64, 73-74.
22. Nel, A.; Xia, T.; Madler, L.; Li, N. Toxic potential of materials at the nanolevel. Science 2006, 311, 622-627.
23. International Commission on Radiological Protection. Human respiratory tract model for radiological protection. Ann. ICRP 1994, 24, 1-482.
24. International Commission on Radiological Protection Human alimentary tract model for radiological protection. ICRP Publication 100. Ann. ICRP 2006, 36, 25-327.
25. International Commission on Radiological Protection Recommendations of the international commission on radiological protection. ICRP Publication 60. Ann. ICRP 1991, 21, 1-3.
26. International Commission on Radiological Protection The 2007 recommendations of the international commission on radiological protection. ICRP. Publication 103. Ann. ICRP 2007, 37, 1-332.
27. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection. ICRP Publication 26; Pergamon Press: Oxford, UK, 1977.
28. Boxall, A. B.; Chaudrhry, Q.; Sinclair, C.; Jones, A.; Aitken, R.; Jefferson, B.; Watts, C. Current and Future Predicted Environmental Exposure to Engineered Nanoparticles; Central Science Laboratory: New York, NY, USA, 2008.
29. Mueller, N. C.; Nowack, B. Exposure modeling of engineered nanoparticles in the environment. Environ. Sci. Technol. 2008, 42, 4447-4453.
30. Oberdorster, G. Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J. Intern. Med. 2010, 267, 89-105.
31. Hinds, W. C. Adhesion of Particles. In Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles; John Wiley & Sons: New York, NY, USA, 1982.
32. Hinds, W. C. Particle Size Statistics. In Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles; John Wiley & Sons: New York, NY, USA, 1982.
33. Cho, W. S.; Duffin, R.; Thielbeer, F.; Bradley, M.; Megson, I. L.; Macnee, W.; Poland, C. A.; Tran, C. L.; Donaldson, K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol. Sci. 2012, 126, 469-477.
34. Donaldson, K.; Schinwald, A.; Murphy, F.; Cho, W. S.; Duffin, R.; Tran, L.; Poland, C. The biologically effective dose in inhalation nanotoxicology. Acc. Chem. Res. 2013, 46, 723-732.
35. Zhang, H.; Ji, Z.; Xia, T.; Meng, H.; Low-Kam, C.; Liu, R.; Pokhrel, S.; Lin, S.; Wang, X.; Liao, Y. P.; et al. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012, 6, 4349-4368.
36. Mercer, T. T. On the role of particle size in the dissolution of lung burdens. Health Phys. 1967, 13, 1211-1221.
37. Moss, O. R.; Kanapilly, G. M. Dissolution of Inhaled Aerosols. In Generation of Aerosols and Facilities for Exposure Experiments; Willeke, K., Ed.; Ann Arbor Science Publishers Inc.: Ann Arbor, MI, USA, 1980; pp. 105-124.
38. Kreyling, W. G. Aerosol particle parameters maintaining lung clearance by intracellular dissolution and translocation. J. Aerosol Sci. 1990, 21, 371-374.
39. Kreyling, W. G.; Godleski, J. J.; Kariya, S. T.; Rose, R. M.; Brain, J. D. In vitro dissolution of uniform cobalt oxide particles by human and canine alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 1990, 2, 413-422.
40. Park, M. V.; Lankveld, D. P.; van Loveren, H.; de Jong, W. H. The status of in vitro toxicity studies in the risk assessment of nanomaterials. Nanomedicine (Lond.) 2009, 4, 669-685.
41. Sohaebuddin, S. K.; Thevenot, P. T.; Baker, D.; Eaton, J. W.; Tang, L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Particle Fibre Toxicol. 2010, 7, doi: 10. 1186/1743-8977-7-22.